COA COA-2026-ZSBTNW matches ILS Laboratories's public record. So this test doesn't rest on our review alone — the lab confirms it too.
The portal confirms the certificate. It can't show that a vial you buy from Medi Peptide is from this batch — compare the lot on yours.
BSBGY88VNot on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
Label 5 mg · Lab measured 5.14 mg
103% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 1.3 mg using the measured mass, against 1.3 mg on the label — 3% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | COA-2026-ZSBTNW |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | ILS Laboratories's portal shows validity only |
| Submitted via | Shop panel (bulk upload) |
| Weight | Listed for information — supplier-provided, not counted |
HPLC purity analysis of Cagrilintide sold by Medi Peptide, ordered by its supplier and performed by ILS Laboratories on August 11, 2026. Reported purity: 99.47%. Net content: 5.14 mg against 5 mg labeled (103% of label). Batch 7-14-26. Sample source: supplier-provided. Certificate of analysis attached.
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| CGL5 | 5 Nov 2026 | Freedom Diagnostics | 99.84% | 112% | Unverified |
| CGL5-A3 | 4 Nov 2026 | Freedom Diagnostics | 99.61% | 100% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion